Paracetamol Poisoning

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Synonyms: acetaminophen poisoning

Paracetamol is widely available and has been around since the 1950s. It is widely prescribed and cheap to buy over-the-counter, making it a common drug taken in overdose. It is a very useful analgesic (alone or in combination) and also is an antipyretic. It is normally found as a 500 mg tablet, but it is often combined with other active ingredients in various preparations.

In the UK it is the most common agent of intentional self harm. Between 2000-2008 there were 90-155 deaths from paracetamol poisoning every year.[1] In addition, there are deaths resulting from paracetamol compounds. It is the most common cause of acute liver failure (ALF).

To reduce the incidence of paracetamol overdose, legislation was passed in the UK in 1998 to limit the number of tablets that could be bought in one purchase: 16 tablets at present (up to 32 tablets in pharmacies). Furthermore, paracetamol was supplied in blister packs making obtaining the actual tablets take longer.

Limiting pack size has reduced sizes of overdoses and numbers of deaths and liver transplantations in England and Wales, but not Scotland,[1]although some authors have disputed the decline.[2]

It is important to remember that, when used at therapeutic levels, paracetamol is usually safe and effective. However taking 4 g per day (or slightly more) for a few days, has been known to result in hepatotoxicity

Paracetamol overdose may occur intentionally and accidentally - the latter due to the high number of combination products available over-the-counter. There are also frequent cases of accidental poisoning in children.

Risk of severe liver damage (ie a peak ALT more than 1000 IU/L)

Based on the dose of paracetamol ingested (mg/kg body weight):
  • Less than 150 mg/kg - unlikely.
  • More than 250 mg/kg - likely.
  • More than 12 g total - potentially fatal.

Paracetamol can cause serious or fatal adverse effects at around 150 mg/kg for many adults. There is considerable interpatient variability which depends on age, health and substances taken with the paracetamol.

The level is higher for young children.

There is a theoretical argument for increased risk with enzyme induction or low glutathione reserves. There are case reports of chronic alcoholics taking relatively small overdose or even therapeutic doses of paracetamol who develop liver failure. However, close examination of these case reports shows up some inconsistencies and suggests that it is unclear that these all provide any substantial evidence supporting the hypothesis.

NEW - log your activity

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

After taken orally, paracetamol is well absorbed from the stomach and small intestine. It reaches a peak plasma concentration in one hour, but this may be 30 minutes if taken in liquid or rapidly absorbed form. It is inactivated by the liver by conjugation leading to two metabolites; glucuronide or sulfate. It is then renally excreted through urine.

  • When taken in overdose the liver conjugation becomes inundated, causing paracetamol to be metabolised by an alternative pathway.
  • This results in a toxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI), which is itself inactivated by glutathione, rapidly preventing any harm.
  • When glutathione stores are depleted to less than approximately 30%, NAPQI reacts with nucleophilic aspects of the cell, leading to necrosis. Necrosis occurs in the liver and in the kidney tubules.

Toxicity is increased in patients with induction of the P450 system through drugs such as rifampicin, phenobarbital, phenytoin, carbamazepine and alcohol. This also occurs in patients with low glutathione reserves, as a product of:

  • Genetic variation.
  • HIV-positive.
  • Malnutrition.
  • Alcohol-related or other liver disease.

Paediatric patients (under the age of 5 years) seem to fare better after paracetamol poisoning, perhaps due to a greater capacity to conjugate with sulfate, enhanced detoxification of NAPQI or greater glutathione stores. However, it should not be assumed that treatment in children should be different than for adults, since no controlled studies have supported any alternative paediatric therapy.

  • Commonly, patients are asymptomatic for the first 24 hours or have nonspecific abdominal symptoms (such as nausea and vomiting).
  • Hepatic necrosis begins to develop after 24 hours (elevated transaminases, right upper quadrant pain and jaundice) and can progress to acute liver failure.
  • Patients may also develop:
    • Encephalopathy.
    • Oliguria.
    • Hypoglycaemia.
    • Renal failure - usually occurs around day three.
    • Lactic acidosis.

History

  • Number of tablets, formulation, any concomitant tablets (include herbal remedies as substances, such as St John's wort - an enzyme inducer).
  • Time of overdose.
  • Suicide risk - was a note left?
  • Any alcohol taken (acute alcohol ingestion will inhibit liver enzymes and may reduce the production of the toxin NAPQI, whereas chronic alcoholism may increase it).

Examination

  • Usually there is very little to find, until the patient develops ALF.
  • If ALF develops, the following may be seen: jaundice, hepatic flap, encephalopathy and tender hepatomegaly.
  • Paracetamol level: take paracetamol level four hours post-ingestion, or as soon as the patient arrives if:
    • Time of overdose is greater than four hours.
    • Staggered overdose (in staggered overdoses, the level is not interpretable except to confirm ingestion).
  • U&E, creatinine - to look for renal failure and have a baseline.
  • LFTs: may be normal if the patient presents early but may rise to ALT >1000 IU/L. This is the enzyme level taken to indicate hepatotoxicity.
  • Glucose: hypoglycaemia is common in hepatic necrosis and capillary blood glucose should be checked hourly.
  • Clotting screen: prothrombin time is the best indicator of severity of liver failure and the INR should be checked 12-hourly.
  • Arterial blood gas; acidosis can occur at a very early stage, even when the patient is asymptomatic. It is seen in up to 10% of patients with ALF.
  • FBC and salicylate levels are not routinely required.

The Medicines and Healthcare products Regulatory Agency (MHRA) changed the guidelines on management of paracetamol overdose in September 2012.[3] These are much simplified and include an updated, single line nomogram.[4]

It should be noted that this nomogram is ultra-conservative and that there is lack of consensus internationally on the management of paracetamol overdose.

All patients who have a timed plasma paracetamol level plotted on or above the line drawn between 100 mg/L at 4 hours and 15 mg/L at 15 hours after ingestion, should receive acetylcysteine. This is regardless of any risk factors they may have for hepatotoxicity.

If there is any doubt about the timing of the ingestion (including a staggered overdose over one hour or more), acetylcysteine should be given without delay. There is no need to refer to the treatment nomogram.

Refer to ICU if there is fulminant liver failure - those treated with N-acetylcysteine (NAC) to the medical team and all para-suicides to the psychiatric team.

NAC is believed to work by a number of protective mechanisms. It acts as a precursor for glutathione, promoting normal conjugation of any remaining paracetamol, and also supplies thiols that function as antioxidants. It is virtually 100% effective in preventing liver damage when given within eight hours of ingestion.[3] After eight hours, efficacy decreases sharply.

The initial dose of acetylcysteine should be given as an infusion over 60 minutes. This should reduce the number of dose-related adverse effects. The infusion should be in 5% glucose, with 0.9% sodium chloride as an alternative. There are now NO specific contra-indications to acetylcysteine use. Even if there is a previously reported reaction, the benefits of treatment outweigh the risks.

Specific weight-related dosing tables are available to guide the health professional.[5] Children receive the same doses and treatment as adults, but with a reduced quantity of intravenous fluid, as fluid overload is a potential risk.

A full treatment course comprises three consecutive doses, administered sequentially, with no break between infusions.

Treatment usually continues for the duration once NAC is started, regardless of any plasma levels. This usually takes 24 hours. NAC may be stopped if started before an appropriate paracetamol level is done, if the level is below the treatment line (when the nomogram is valid) and the patient has normal LFTs and is asymptomatic.  NAC is usually continued if blood tests are still significantly abnormal after the first course. The dose depends on local protocols, but is often at the rate of the third (last given) bag.

Prior to discharge it is sensible to re-check the INR, renal tests and LFTs. Patients should be advised to return if vomiting occurs after discharge.

The treatment of patients presenting more than 24 hours after ingestion is controversial. Management is detailed on Toxbase® and is similar to presentation between 8 and 24 hours after the overdose.

  • Measure INR, creatinine, ALT and venous blood acid/base balance or bicarbonate.
  • If any of these is abnormal discuss with your nearest National Poisons Information Centre (0870 600 6266).
Beware if:
  • The patient is on long-term treatment with enzyme inducers - eg, carbamazepine, phenobarbital, phenytoin, primidone, rifampicin, St John's wort.
  • The patient regularly consumes alcohol in excess.
  • The patient has pre-existing liver disease.
  • The patient is likely to be glutathione-depleted - eg, eating disorders, cystic fibrosis, HIV infection.

NB: the plasma paracetamol concentration >24 hours after overdose is likely to be below the limit of detection, even after substantial overdose. A measurable paracetamol concentration more than 24 hours after ingestion either indicates a very large overdose, or suggests a mistake in time of ingestion, or a staggered overdose. A full course of antidotal therapy should normally be given to patients in whom paracetamol is detected.

Paracetamol is the most common drug taken in overdose during pregnancy.[6] The resulting toxic metabolites can cross the placenta and lead to hepatocellular necrosis of maternal and fetal liver cells.

NAC can bind the toxic metabolites in the mother and fetal circulation as it crosses the placenta. NAC appears to be safe during pregnancy and therefore should be administered.

  • Encephalopathy or raised intracranial pressure (ICP). Signs of CNS oedema include BP >160/90 mm Hg (sustained) or brief rises (systolic >200 mm Hg), bradycardia, decerebrate posture, extensor spasms, and poor pupil responses. ICP monitoring can help.
  • INR >2.0 at or before 48 hours or >3.5 at or before 72 hours (so measure INR every 12 hours). Peak elevation occurs around 72-96 hours. LFTs are not good markers of hepatocyte death.
  • Renal impairment (creatinine >200 μmol/L). Monitor urine flow and daily U&E and serum creatinine (use haemodialysis if >400 μmol/L).
  • Blood pH <7.3 (lactic acidosis results in tissue hypoxia).
  • Systolic BP <80 mm Hg despite adequate fluid resuscitation.
  • Hypoglycaemia.
  • Metabolic acidosis (pH <7.3 or bicarbonate <18 mmol/L).

King's College Hospital criteria for liver transplantation in paracetamol-induced acute liver failure

List for transplantation if:[7]
  • arterial pH <7.3 or arterial lactate >3.0 mmol/L after adequate fluid resuscitation, OR
  • if all three of the following occur in a 24-hour period:
    • Creatinine >300 μmol/L.
    • PT >100 seconds (INR >6.5).
    • Grade III/IV encephalopathy.
Strongly consider transplantation if:
  • Arterial lactate >3.5 mmol/L after early fluid resuscitation.

The mortality from severe liver failure is <5% with good supportive care.

Although liver transplantation only has a limited application,[8] patients must be identified as early as possible, preferably on the second day. Current data indicate a poor prognosis if:

  • An arterial pH <7.30 (hydrogen ion concentration >50 nmol/L) on or after day two following overdose (found in ~70% of cases with a poor prognosis).
  • A combination of a prothrombin time of more than 100 seconds (INR >6.5), plasma creatinine >300 μmol/L and grade 3 or 4 hepatic encephalopathy (only a 17% survival rate).
  • An increase in prothrombin time between day three and day four after overdose.

Liver transplantation is probably contra-indicated in patients with severe hypotension, severe cerebral oedema and serious infection.

Further reading & references

  1. Hawton K et al; Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: a comparative study Biomed central (2011)
  2. Bateman DN; Limiting paracetamol pack size: has it worked in the UK? Clin Toxicol (Phila). 2009 Jul;47(6):536-41.
  3. MRHA - Paracetamol overdose: new guidance on treatment with intravenous acetylcysteine; Medicines and Healthcare products Regulatory Agency (Sept 2012)
  4. MRHA - Paracetamol overdose - revised single line treatment nomogram; Medicines and Healthcare products Regulatory Agency, Sept 2012
  5. MRHA - Acetylcysteine 200 mg/ml injection for infusion; Medicines and Healthcare products Regulatory Agency; administration information for healthcare professionals
  6. Wilkes JM, Clark LE, Herrera JL; Acetaminophen overdose in pregnancy; South Med J. 2005 Nov;98(11):1118-22.
  7. Dargan PI, Jones AL; Acetaminophen poisoning: an update for the intensivist.; Crit Care. 2002 Apr;6(2):108-10. Epub 2002 Mar 14.
  8. Toxbase®

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Hayley Willacy
Current Version:
Peer Reviewer:
Dr Adrian Bonsall
Last Checked:
04/01/2013
Document ID:
529 (v5)
© EMIS